She co-founded IMDx while completing Harvard Medical School. Raising $40M in funding and closing almost another $40M in strategic deals the company had five FDA cleared and eight CE marked products before being sold to Qiagen. Alice has been an advisor to Third Rock Ventures, MIT and GE Healthcare Ventures. She holds multiple patents in personalized medicine and has been honored with numerous awards including a “Top 50 Innovators” by the World Economic Forum.